FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4206998985> ?p ?o ?g. }

• W4206998985 endingPage "226" @default.
• W4206998985 startingPage "219" @default.
• W4206998985 abstract "Aim. Study of multi-year sales statistics in pharmacy market segment to assess the volume and structure of consumed cardiovascular and antithrombotic drugs under COVID-19 pandemic conditions.&#x0D; Material and methods. Data on nomenclature and sales volumes of drugs in pharmacy segment of Samara region in 20152020.&#x0D; Results. It is shown that the share of basic cardiovascular drugs in physical terms is insignificant (5.2-3%). The largest volume of sales are drugs of angiotensin-converting enzyme inhibitor group (28%) and b-adrenoblockers (23.5%). Fixed combinations of hypotensive drugs account for only 13% of the volume of sold basic cardiovascular drugs, and the share of statins is 7.6%, which does not correspond to their role as the most effective drugs in primary and secondary cardiac prevention. The share of antithrombotic drugs in total sales in volume terms was 0.45% in 20152019. In absolute terms, sales of anticoagulants and disaggregants increased in 20182020, which was accompanied by an average 15% increase in the cost per daily dose. Among disaggregants, acetylsalicylic acid (66.6%), clopidogrel (21.6%), and dipyridamole (10.2%) are most frequently sold. The share of disaggregants in sales fell from 74.8 to 57.6% at the expense of acetylsalicylic acid drugs. In 2020, consumption of dipyridamole increased significantly to 16.6% due to inclusion of the drug in protocols for managing patients with COVID-19. Among anticoagulants, the proportion of new oral medications is characterized by a progressive increase from 7.8% in 2015 to 27% in 2020. During the COVID-19 pandemic, the most demanded group of Xa factor blockers is dominated by apixaban (63.8%), which can be explained by the lower cost (by 16%) of a daily equivalent dose compared to rivaroxaban.&#x0D; Conclusion. Low consumption of basic cardiovascular drugs among the population of Samara region, especially statins and combined hypotensive drugs was observed. During COVID-19 pandemic there was an increase in consumption of antithrombotic drugs, due to dipyridamole and new oral anticoagulants." @default.
• W4206998985 created "2022-01-26" @default.
• W4206998985 creator A5007629094 @default.
• W4206998985 creator A5008911252 @default.
• W4206998985 creator A5035134425 @default.
• W4206998985 creator A5038311789 @default.
• W4206998985 creator A5076193540 @default.
• W4206998985 date "2021-12-15" @default.
• W4206998985 modified "2023-09-26" @default.
• W4206998985 title "Consumption of cardiovascular and antithrombotic drugs during the spread of coronavirus infection in retail sector of the Samara region pharmaceutical market" @default.
• W4206998985 cites W2342209858 @default.
• W4206998985 cites W3017792836 @default.
• W4206998985 cites W3039530416 @default.
• W4206998985 cites W3094845185 @default.
• W4206998985 cites W3111692544 @default.
• W4206998985 cites W3113178943 @default.
• W4206998985 cites W3122390927 @default.
• W4206998985 cites W3138221603 @default.
• W4206998985 cites W3183633242 @default.
• W4206998985 doi "https://doi.org/10.17816/22217185.2021.4.201282" @default.
• W4206998985 hasPublicationYear "2021" @default.
• W4206998985 type Work @default.
• W4206998985 citedByCount "0" @default.
• W4206998985 crossrefType "journal-article" @default.
• W4206998985 hasAuthorship W4206998985A5007629094 @default.
• W4206998985 hasAuthorship W4206998985A5008911252 @default.
• W4206998985 hasAuthorship W4206998985A5035134425 @default.
• W4206998985 hasAuthorship W4206998985A5038311789 @default.
• W4206998985 hasAuthorship W4206998985A5076193540 @default.
• W4206998985 hasBestOaLocation W42069989851 @default.
• W4206998985 hasConcept C100406419 @default.
• W4206998985 hasConcept C104863432 @default.
• W4206998985 hasConcept C126322002 @default.
• W4206998985 hasConcept C144133560 @default.
• W4206998985 hasConcept C2776890861 @default.
• W4206998985 hasConcept C2777015399 @default.
• W4206998985 hasConcept C2780035454 @default.
• W4206998985 hasConcept C512399662 @default.
• W4206998985 hasConcept C71924100 @default.
• W4206998985 hasConcept C98274493 @default.
• W4206998985 hasConceptScore W4206998985C100406419 @default.
• W4206998985 hasConceptScore W4206998985C104863432 @default.
• W4206998985 hasConceptScore W4206998985C126322002 @default.
• W4206998985 hasConceptScore W4206998985C144133560 @default.
• W4206998985 hasConceptScore W4206998985C2776890861 @default.
• W4206998985 hasConceptScore W4206998985C2777015399 @default.
• W4206998985 hasConceptScore W4206998985C2780035454 @default.
• W4206998985 hasConceptScore W4206998985C512399662 @default.
• W4206998985 hasConceptScore W4206998985C71924100 @default.
• W4206998985 hasConceptScore W4206998985C98274493 @default.
• W4206998985 hasIssue "4" @default.
• W4206998985 hasLocation W42069989851 @default.
• W4206998985 hasLocation W42069989852 @default.
• W4206998985 hasOpenAccess W4206998985 @default.
• W4206998985 hasPrimaryLocation W42069989851 @default.
• W4206998985 hasRelatedWork W1929072719 @default.
• W4206998985 hasRelatedWork W2042806753 @default.
• W4206998985 hasRelatedWork W2095070822 @default.
• W4206998985 hasRelatedWork W2204358083 @default.
• W4206998985 hasRelatedWork W2410003696 @default.
• W4206998985 hasRelatedWork W2437895651 @default.
• W4206998985 hasRelatedWork W2462760285 @default.
• W4206998985 hasRelatedWork W2517015656 @default.
• W4206998985 hasRelatedWork W2599306953 @default.
• W4206998985 hasRelatedWork W2883640684 @default.
• W4206998985 hasVolume "12" @default.
• W4206998985 isParatext "false" @default.
• W4206998985 isRetracted "false" @default.
• W4206998985 workType "article" @default.